New drug takes on keytruda in fight against lung cancer recurrence
NCT ID NCT07180862
Summary
This study is testing whether a new drug called BAT3306 works similarly to the established drug Keytruda in preventing lung cancer from returning after surgery. The trial will involve 140 adults with early-stage lung cancer who have had their tumors completely removed. Researchers will compare how the two drugs move through the body, their safety, and their effectiveness at keeping cancer from coming back.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Union Hospital Tongji Medical College Huazhong University of Science & Technology
RECRUITINGWuhan, Hubei, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.